Overview of Anti-Tuberculosis Treatment Compliance in Pulmonary Tuberculosis Patients

Author:

Rohmatika Julia,Aisyah Popy SityORCID,Gartika NinaORCID

Abstract

This research was motivated by an increase in pulmonary tuberculosis cases in 2022 of 10% and cases of loss to follow-up treatment of 11.25%. This research aimed to determine the description of Anti-TB treatment compliance in pulmonary tuberculosis patients at the Pameungpeuk Community Health Center. This research method uses descriptive quantitative with a cross-sectional design. The instrument used the MARS-5 questionnaire with 120 pulmonary tuberculosis patient respondents who received treatment at the health center. The sampling technique uses a Total sampling technique with criteria for patients undergoing treatment for a minimum of three months from 17-74 years. The research results were obtained from univariate analysis with the results that most were female (52.5%), almost half were in their late teens (32.5%), most had a high school education (60%), almost half the length of treatment was in the intensive phase (48 .3%), most experienced side effects (64.2%), most underwent routine examinations (75%), most had treatment supervision (60%), high compliance (58.3%), moderate compliance (41, 7%). It can be concluded that compliance is influenced by age, education, treatment supervision, side effects, length of treatment, routine check-ups, and gender and it is hoped that community health centers can optimize educational strategies for handling side effects to obtain maximum compliance results.

Publisher

The Indonesian Institute of Science and Technology Research

Reference16 articles.

1. Inayah, S., & Wahyono, B. (2019). Penanggulangan Tuberkulosis Paru dengan Strategi DOTS. HIGEIA (Journal of Public Health Research and Development), 3(2), 223-233.

2. WHO. Tuberculosis. Retrieved January 6, 2023, from https://www.who.int/southeastasia/health-topics/tuberculosis

3. Kemenkes, R. I. (2022). Melalui Kegiatan INA–TIME 2022 Ke-4, Menkes Budi Minta 90% Penderita TBC Dapat Terdeteksi di Tahun 2024 [WWW Document]. Direktorat Jenderal Pencegahan dan Pengendalian Penyakit. Available: http://p2p.kemkes.go.id/melalui-ina-time-2022-ke-4-menkes-budi-minta-90-penderita-tbc-dapat-terdeteksi-di-tahun-2024/

4. Silaban, J., Harahap, S., & Silaban, V. F. (2024). Relationship of Self Effectiveness with Compliance of Eating Medicines for Pulmonary Tuberculosis Sufferers. Indonesian Journal of Global Health Research, 6(2), 969-976.

5. Sarwani SR, D., & Nurlaela, S. (2012). Faktor Risiko Multidrug Resistant Tuberculosis (MDR-TB). Jurnal kesehatan masyarakat, 8(1), 60-66.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3